• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON BD PHASEAL¿ SECONDARY SET C61; ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON BD PHASEAL¿ SECONDARY SET C61; ADMINISTRATION SET Back to Search Results
Catalog Number 515302
Medical Device Problem Code Leak/Splash (1354)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 05/06/2019
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The manufacturing location for this product is (b)(4).This site is not registered with the fda.Therefore, bd corporate headquarters in (b)(4) has been listed and the (b)(4) fda registration number has been used for the manufacture report number.A device evaluation and/or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.
 
Event or Problem Description
It was reported that bd phaseal¿ secondary set c61 leaked.This occurred on 3 occasions.The following information was provided by the initial reporter: leakage from c61 they have noticed the leakage at pharmacy right after sytostatic preparation.Leakage comes from tubing (the contact part to spike).They have realized same kind of problems earlier this month, but haven¿t been reporting those.
 
Additional Manufacturer Narrative
H.6.Investigation: dhr review was done and no issues were reported during production of this lot.No sample received for this complaint, picture was not provided.Ct scan was done on leaking sample which was segregated during production.After this scan additional tests were done on spike component and concentricity of lower part of spike component which caused molding deficit on one side of component.Capa#891423 was initiated.
 
Event or Problem Description
It was reported that bd phaseal¿ secondary set c61 leaked.This occurred on 3 occasions.The following information was provided by the initial reporter: leakage from c61 they have noticed the leakage at pharmacy right after sytostatic preparation.Leakage comes from tubing (the contact part to spike).They have realized same kind of problems earlier this month, but haven¿t been reporting those.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD PHASEAL¿ SECONDARY SET C61
Common Device Name
ADMINISTRATION SET
Manufacturer (Section D)
BECTON DICKINSON
1 becton drive
franklin lakes NJ 07417
MDR Report Key8632607
Report Number2243072-2019-00987
Device Sequence Number19355580
Product Code FPA
UDI-Device Identifier00382905153020
UDI-Public382905153020
Combination Product (Y/N)N
Initial Reporter CountryFI
PMA/510(K) Number
N/A
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,other,user facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 06/10/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Other
Device Expiration Date08/31/2022
Device Catalogue Number515302
Device Lot Number1011580
Initial Date Received by Manufacturer 05/07/2019
Supplement Date Received by Manufacturer05/07/2019
Initial Report FDA Received Date05/22/2019
Supplement Report FDA Received Date06/10/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
-
-